Suzuki M, Satoh S
Clin Exp Hypertens A. 1984;6(6):1227-35. doi: 10.3109/10641968409039593.
The present study was designed to investigate the effect of bradykinin on renin release in relation to prostaglandins by use of indomethacin, a cyclooxygenase inhibitor, in pentobarbital-anesthetized rats. A nonhypotensive dose of bradykinin (1 microgram/kg X min), which was infused intrarenally, significantly increased plasma renin activity approximately 1.8-fold as compared to the control period. In indomethacin (5 mg/kg, i.v.)-pretreated rats, bradykinin did not significantly increase plasma renin activity. These results suggest that bradykinin does not directly increase plasma renin activity and that prostaglandins may participate in the bradykinin-induced renin release under these experimental conditions.
本研究旨在通过在戊巴比妥麻醉的大鼠中使用环氧化酶抑制剂吲哚美辛,研究缓激肽对与前列腺素相关的肾素释放的影响。肾内输注非降压剂量的缓激肽(1微克/千克×分钟),与对照期相比,血浆肾素活性显著增加约1.8倍。在吲哚美辛(5毫克/千克,静脉注射)预处理的大鼠中,缓激肽并未显著增加血浆肾素活性。这些结果表明,缓激肽不会直接增加血浆肾素活性,并且在这些实验条件下,前列腺素可能参与缓激肽诱导的肾素释放。